In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis
article
OA: closed
CC0
⤵ 9 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This in vitro study investigated the effect of a gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (33)
- Danazol Suppresses Both Spontaneous and Activated Human Lymphocyte‐Mediated Cytotoxicity via openalex
- Danazol Suppresses the Production of Interleukin‐1β and Tumor Necrosis Factor by Human Monocytes via openalex
- Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy via openalex
- Immunomodulation in women with endometriosis receiving GnRH agonist via openalex
- Immunosuppressive effect of danazol on lymphocyte-mediated cytotoxicity toward human endometrial stromal cells via openalex
- Immunosuppressive effects of danazol in vitro via openalex
- Natural cytotoxicity and gnrh agonist administration in advanced endometriosis: positive modulation on natural killer activity via openalex
- Natural killer activity in stage III and IV endometriosis via openalex
- Natural killer cell activity in endometriosis: correlation between serum estradiol levels and cytotoxicity. via openalex
- Pathogenesis of Endometriosis via openalex
- Peritoneal natural killer cytotoxicity and CD25+CD3+ lymphocyte subpopulation are decreased in women with stage III–IV endometriosis via openalex
- The role of cell-mediated immunity in pathogenesis of endometriosis. via openalex
- W2115554886 via openalex
- W2157269038 via openalex
- W2159228424 via openalex
- W2226027224 via openalex
- W2409202770 via openalex
- W2417327597 via openalex
- W4313313358 via openalex
- W6608173405 via openalex
- W11141567 via openalex
- W6718081599 via openalex
- W141728048 via openalex
- W1549355081 via openalex
- W1969492100 via openalex
- W1986465498 via openalex
- W1994161601 via openalex
- W1999237928 via openalex
- W2011726222 via openalex
- W2023454828 via openalex
- W2039004785 via openalex
- W2067332996 via openalex
- W2085452079 via openalex
Cited by (9)
- Immune and endocrine regulation in endometriosis: what we know 2023
- The pathogenesis of endometriosis: clues from the immunological evidence 2021
- Recombinant IL-2: clinical efficacy and pathogenetic rationale for use in external genital endometriosis 2021
- A History of Endometriosis Is Associated With Decreased Peripheral NK Cytotoxicity and Increased Infiltration of Uterine CD68+ Macrophages 2021
- NK Cells as Potential Targets for Immunotherapy in Endometriosis 2019
- Natural Killer Cells: Key Players in Endometriosis 2015
- Impact of ovarian endometrioma on assisted reproduction outcomes 2006
- Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies 2005
- Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies 2005
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:12:38.158000+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK